Pediatrix Medical (MD) Other financing activities (2009 - 2025)

Pediatrix Medical has disclosed Other financing activities across 17 years of filings, most recently posting $95000.0 for Q4 2025.

• In Q4 2025, Other financing activities rose 14.46% year-over-year to $95000.0; the TTM figure through Mar 2026 stood at $38000.0 (up 416.67% YoY), while the FY2025 annual figure was -$63000.0, down 146.67% from the prior year.
• Other financing activities advanced to $95000.0 in Q4 2025, from -$23000.0 in the prior quarter.
• Over the last five years, Other financing activities for MD reached as high as $8.3 million in Q3 2022 and fell as low as -$7.6 million in Q2 2022.
• The 5-year median for Other financing activities is $33000.0 (2024), against an average of $264894.7.
• The widest YoY moves for Other financing activities: up 4292.59% in 2022, down 597.4% in 2022.
• A 5-year view of Other financing activities shows it stood at $3.0 million in 2021, then plunged by 75.87% to $732000.0 in 2022, then plunged by 144.81% to -$328000.0 in 2023, then surged by 125.3% to $83000.0 in 2024, then rose by 14.46% to $95000.0 in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $95000.0, -$23000.0, and -$34000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.